Category: COVID-19

Posted on | Posted on John Murphy | 2 Comments on Therapeutic Strategies and Clinical Trials in Long COVID: Anticoagulants, Fibrinolytics, Endothelial Support, Immunomodulators, and RECOVER Protocols

Therapeutic Strategies and Clinical Trials in Long COVID: Anticoagulants, Fibrinolytics, Endothelial Support, Immunomodulators, and RECOVER Protocols

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Neuroinflammatory and Glutamatergic Dysregulation in Long COVID: Treating Brain Fog, Confusion, and Depression

Neuroinflammatory and Glutamatergic Dysregulation in Long COVID: Treating Brain Fog, Confusion, and Depression

John Murphy, – President, COVID-19 Long-haul Foundation Pathophysiology of Long COVID Neurocognitive Sequelae Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is increasingly recognized as a chronic, multisystemic condition…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Endothelial Dysfunction and Spike Protein Persistence in Long COVID: Mechanisms, Vulnerabilities, and Clinical Evidence

Endothelial Dysfunction and Spike Protein Persistence in Long COVID: Mechanisms, Vulnerabilities, and Clinical Evidence

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent symptoms affecting multiple organ systems. Among its most compelling…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on COVID Research Gaps and Future Directions: Standardization, Longitudinal Recovery, AI-Driven Biomarkers, and Policy Reform

COVID Research Gaps and Future Directions: Standardization, Longitudinal Recovery, AI-Driven Biomarkers, and Policy Reform

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), remains a poorly defined and under-researched condition affecting millions globally. Despite its prevalence,…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Exploring the Link Between COVID-19 and Liver Abscess Formation

Exploring the Link Between COVID-19 and Liver Abscess Formation

Ramlakhan S. Verma • Shailendra Pal Singh • Gaurav Mishra • Vikas K. Patel • Vipin Gupta, DOI: 10.7759/cureus.94136  Abstract Background Liver abscess is a potential concern among liver health complications. With severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2)…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Systemic Reluctance: Medical Inertia and the Pharmaceutical Industry’s Influence on Long COVID Treatment

Systemic Reluctance: Medical Inertia and the Pharmaceutical Industry’s Influence on Long COVID Treatment

Abstract Despite the global burden of Long COVID, the medical profession has demonstrated a striking reluctance to engage in consistent diagnosis, treatment, and research. This article explores the multifactorial roots…[...]

Read More